Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: July 7, 2009
Last updated: April 12, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)